O-026 Combination of encorafenib and cetuximab with or without alpelisib in patients with advanced BRAF-mutant colorectal cancer (BRAFm CRC): phase 2 results
Titel:
O-026 Combination of encorafenib and cetuximab with or without alpelisib in patients with advanced BRAF-mutant colorectal cancer (BRAFm CRC): phase 2 results
Auteur:
Tabernero, J. van Geel, R. Guren, T. Yaeger, R. Spreafico, A. Faris, J. Yoshino, T. Yamada, Y. Kim Tae, W. Bendell, J. Schuler, M. Lenz, H.-J. Eskens, F. Desai, J. Hochster, H. Avsar, E. Demuth, T. Sandor, V. Elez, E. Schellens, J.